TrialCancer chemotherapy and pharmacology2011

Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer.

Allyson J Ocean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.